Evidence-Based Minireview: Strategies to manage a severely HLA-alloimmunized patient with refractory thrombocytopenia.

IF 2.9 3区教育学 Q1 EDUCATION, SCIENTIFIC DISCIPLINES Hematology. American Society of Hematology. Education Program Pub Date : 2022-12-09 DOI:10.1182/hematology.2022000416

Debbie Jiang, Sandhya R Panch

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

基于证据的迷你综述:处理严重hla同种异体免疫患者难治性血小板减少症的策略。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Hematology. American Society of Hematology. Education Program EDUCATION, SCIENTIFIC DISCIPLINES-HEMATOLOGY

CiteScore

4.70

自引率

3.30%

发文量

期刊介绍： Hematology, the ASH Education Program, is published annually by the American Society of Hematology (ASH) in one volume per year.

期刊最新文献

Atypical CML: diagnosis and treatment. Langerhans cell histiocytosis: promises and caveats of targeted therapies in high-risk and CNS disease. Multiple myeloma: a paradigm for blending community and academic care. The sum of the parts: what we can and cannot learn from comorbidity scores in allogeneic transplantation. Thrombopoietin receptor agonists for chemotherapy-induced thrombocytopenia: a new solution for an old problem.